Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jan;42(1):147-57.
doi: 10.1002/eji.201141927.

HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis

Affiliations
Free PMC article

HIV-1 infection alters CD4+ memory T-cell phenotype at the site of disease in extrapulmonary tuberculosis

Kerryn Matthews et al. Eur J Immunol. 2012 Jan.
Free PMC article

Abstract

HIV-1-infected people have an increased risk of developing extrapulmonary tuberculosis (TB), the immunopathogenesis of which is poorly understood. Here, we conducted a detailed immunological analysis of human pericardial TB, to determine the effect of HIV-1 co-infection on the phenotype of Mycobacterium tuberculosis (MTB)-specific memory T cells and the role of polyfunctional T cells at the disease site, using cells from pericardial fluid and blood of 74 patients with (n = 50) and without (n = 24) HIV-1 co-infection. The MTB antigen-induced IFN-γ response was elevated at the disease site, irrespective of HIV-1 status or antigenic stimulant. However, the IFN-γ ELISpot showed no clear evidence of increased numbers of antigen-specific cells at the disease site except for ESAT-6 in HIV-1 uninfected individuals (p = 0.009). Flow cytometric analysis showed that CD4+ memory T cells in the pericardial fluid of HIV-1-infected patients were of a less differentiated phenotype, with the presence of polyfunctional CD4+ T cells expressing TNF, IL-2 and IFN-γ. These results indicate that HIV-1 infection results in altered phenotype and function of MTB-specific CD4+ T cells at the disease site, which may contribute to the increased risk of developing TB at all stages of HIV-1 infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Pericardial TB patients have increased antigen-specific IFN-γ secretion in the pericardial fluid compared with blood. Undiluted blood and pericardial fluid were cultured overnight either unstimulated (NIL) or stimulated with ESAT-6 and CFP-10. IFN-γ concentration (ng/mL) was determined by ELISA and bars represent medians. Each circle is representative of one sample. P-Values indicate the differences between blood and pericardial fluid using the Wilcoxon-matched pairs test.
Figure 2
Figure 2
Increased numbers of ESAT-6-specific IFN-γ-producing cells in the pericardial fluid of HIV-1-uninfected patients. PBMCs and PFCs were assessed for antigen-specific IFN-γ responses by ELISpot assay. Each circle represents the number of IFN-γ spot forming cells/106 cells in response to ESAT-6 and CFP-10, corrected for unstimulated control wells. The number of ESAT-6 specific IFN-γ spot forming cells/106 cells was significantly higher in the pericardial fluid of the HIV-1-uninfected patients compared with HIV-1-infected patients (p=0.009, Mann–Whitney U test).
Figure 3
Figure 3
Flow cytometric analysis of CD4+ memory T cells in the pericardial fluid. (A) PFCs from HIV-1-uninfected (n=8, closed circles) and HIV-1-infected (n=7, open circles) patients were stimulated overnight in the presence of hkH37Rv, followed by surface staining for four-colour flow cytometry using CD4+, CD45RA and the co-stimulatory marker CD28. A significantly higher proportion of CD28+CD45RA cells at the disease site of the HIV-1-infected patients (p=0.04, Mann–Whitney U test), indicates a shift towards a less differentiated memory phenotype. Bars represent medians. (B) PFCs from HIV-1-uninfected (n=8, closed circles) and HIV-1-infected (n=10, open circles) patients were stimulated overnight in the presence of hkH37Rv, followed by surface staining for eight colour flow cytometry, including CD3, CD4, CD45RA, the co-stimulatory marker CD27 as well as CCR5 to phenotype the cells at the site of disease. The data indicate that CD4+ memory T cells in the pericardial fluid of HIV-1-infected patients lack the CCR5 receptor. A significantly higher proportion of CCR5CD27CD45RA cells (p=0.02), and significantly fewer CCR5+CD27+CD45RA+ cells (p=0.012) were found at the disease site of HIV-1-infected patients, compared with HIV-1-uninfected patients (Mann–Whitney U test). Bars represent medians.
Figure 4
Figure 4
Increased cytokine-secreting capacity in the pericardium compared with that in blood, irrespective of HIV-1 status. Total cytokine secretion in response to ESAT-6+CFP-10 in blood (closed circles) and pericardial fluid (open circles) of (A) HIV-1-uninfected and (B) HIV-1-infected patients. Bars represent medians. Statistically significant differences between blood and fluid are indicated (Mann–Whitney U test).
Figure 5
Figure 5
Polyfunctional CD4+ T cells are present at the disease site. CD3+CD4+ T cells were assessed for the expression of various combinations of IFN-γ, IL-2 and TNF in response to (A) hkH37Rv and (B) ESAT-6+CFP-10 stimulation, in the pericardial fluid of HIV-1-uninfected (closed circles) and HIV-1-infected (open circles) patients. (C) Pie-charts illustrate the overall proportional contribution of cytokine expressing cells to the antigen-specific response in blood and pericardial fluid. 1+: any one cytokine, 2+: any two cytokines, 3+: all three cytokines. IL-2 single-positive cells were proportionally expanded in the HIV-1-infected pericardial fluid compared with the uninfected in response to ESAT-6+CFP-10 (B, p=0.024, Mann–Whitney U test).
Figure 6
Figure 6
HIV viral load is increased in pericardial fluid compared with blood. HIV-1 RNA copies/mL were significantly elevated in matched pericardial fluid compared with serum from HIV-1-infected patients (p=0.002, Wilcoxon-matched pairs test). Squares represent the patient on ARV treatment at enrolment into the study.

Similar articles

Cited by

References

    1. Meintjes G, Wilkinson RJ. Undiagnosed active tuberculosis in HIV-infected patients commencing antiretroviral therapy. Clin. Infect. Dis. 2010;51:830–832. - PubMed
    1. WHO. Global tuberculosis control: key findings from the December 2009 WHO report. Wkly Epidemiol. Rec. 2010;85:69–80. - PubMed
    1. Wilkinson RJ, Vordermeier HM, Wilkinson KA, Sjolund A, Moreno C, Pasvol G, Ivanyi J. Peptide-specific T cell response to Mycobacterium tuberculosis: clinical spectrum, compartmentalization, and effect of chemotherapy. J. Infect. Dis. 1998;178:760–768. - PubMed
    1. Pathan AA, Wilkinson KA, Klenerman P, McShane H, Davidson RN, Pasvol G, Hill AV, et al. Direct ex vivo analysis of antigen-specific IFN-gamma-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J. Immunol. 2001;167:5217–5225. - PubMed
    1. Mayosi BM, Wiysonge CS, Ntsekhe M, Gumedze F, Volmink JA, Maartens G, Aje A, et al. Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. South Afr. Med. J. 2008;98:36–40. - PubMed

Publication types

MeSH terms